| Literature DB >> 21148601 |
N Ruperto1, L M Hanrahan, G S Alarcón, H M Belmont, R L Brey, P Brunetta, J P Buyon, M I Costner, M E Cronin, M A Dooley, G Filocamo, D Fiorentino, P R Fortin, A G Franks, G Gilkeson, E Ginzler, C Gordon, J Grossman, B Hahn, D A Isenberg, K C Kalunian, M Petri, L Sammaritano, J Sánchez-Guerrero, R D Sontheimer, V Strand, M Urowitz, J M von Feldt, V P Werth, J T Merrill.
Abstract
The Lupus Foundation of America (LFA) convened an international working group to obtain a consensus definition of disease flare in lupus. With help from the Paediatric Rheumatology International Trials Organization (PRINTO), two web-based Delphi surveys of physicians were conducted. Subsequently, the LFA held a second consensus conference followed by a third Delphi survey to reach a community-wide agreement for flare definition. Sixty-nine of the 120 (57.5%) polled physicians responded to the first survey. Fifty-nine of the responses were available to draft 12 preliminary statements, which were circulated in the second survey. Eighty-seven of 118 (74%) physicians completed the second survey, with an agreement of 70% for 9/12 (75%) statements. During the second conference, three alternative flare definitions were consolidated and sent back to the international community. One hundred and sixteen of 146 (79.5%) responded, with agreement by 71/116 (61%) for the following definition: "A flare is a measurable increase in disease activity in one or more organ systems involving new or worse clinical signs and symptoms and/or laboratory measurements. It must be considered clinically significant by the assessor and usually there would be at least consideration of a change or an increase in treatment." The LFA proposes this definition for lupus flare on the basis of its high face validity.Mesh:
Year: 2010 PMID: 21148601 DOI: 10.1177/0961203310388445
Source DB: PubMed Journal: Lupus ISSN: 0961-2033 Impact factor: 2.911